Molecule Details
| InChIKey | MTAFDCDGNPHAKS-UHFFFAOYSA-N |
|---|---|
| Compound Name | 5-Methyl-4-[4-[6-[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]-3-(2-pyrrolidin-1-ylethylamino)pyridin-2-yl]piperidin-1-yl]-5,7-dihydropyrrolo[2,3-d]pyrimidin-6-one |
| Canonical SMILES | CC1C(=O)Nc2ncnc(N3CCC(c4nc(-c5cc(C(F)(F)F)nn5C)ccc4NCCN4CCCC4)CC3)c21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 9.16 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P31749 | AKT1 | Homo sapiens | Human | PF00169 PF00069 PF00433 | 9.2 | IC50 | ChEMBL;BindingDB |
| Q15418 | RPS6KA1 | Homo sapiens | Human | PF00069 PF00433 | 9.2 | IC50 | ChEMBL;BindingDB |
| P21817 | RYR1 | Homo sapiens | Human | PF08709 PF00520 PF02815 PF08454 PF06459 PF01365 PF21119 PF02026 PF00622 | 9.1 | IC50 | BindingDB |